CV industry veteran succeeds Howlett as Lombard CEO
This article was originally published in Clinica
Executive Summary
John Rush, a medical device industry veteran with particular experience in the cardiovascular sector, has succeeded Brian Howlett as CEO of UK stent graft developer Lombard Medical Technologies. Mr Rush, a US national, spent 10 years at SciMed Life Systems (which was bought by Boston Scientific in 1994) in various senior sales and marketing and management roles. He has been president and CEO of several small-cap companies, most recently at North American Scientific (NAS), where he led the firm's reorganisation and financial recovery. Mr Rush is expected to take Lombard through the next growth phase, as it expands commercialisation in Europe and secures FDA approval for its flagship Aorfix device. His predecessor, Mr Howlett, will be retiring after nearly four years at Lombard's helm, but will remain with the London firm as executive director until the end of March 2010 to oversee the transition.